The biotech stock rally that began in April 2025 has not stopped, and if anything, has accelerated.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: Roche drug sets new standard for KRAS-driven lung cancer | 5 | 7 | 02-07-2026 |
| 2 | STAT+: A year after distressed buyout, what’s become of Bluebird Bio? | 0 | 5 | 02-07-2026 |
| 3 | STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better | 0 | 7 | 25-06-2026 |
| 4 | ASX set to slide, tech stocks weigh down Wall Street | -2 | 5 | 01-07-2026 |
| 5 | STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong | 0 | 5 | 02-07-2026 |
| 6 | Pandemic darlings Moderna, BioNTech are now on two different paths | 0 | 7 | 31-07-2025 |
| 7 | STAT+: Embryo editing advances reignite ethical debates | 0 | 5 | 26-06-2026 |
| 8 | US stocks chalk up biggest quarterly gain in six years | 2 | 7 | 30-06-2026 |
| 9 | Nifty heading to 25,000, Bank Nifty to 60,000 soon; prefer private banks, NBFCs over PSU banks: CA Rudramurthy BV | 6 | 7 | 03-07-2026 |
| 10 | Warren Buffett's 11-Word Stock Market Warning Goes Viral as AI Rally Fuels Bubble Fears | -2 | 6 | 04-07-2026 |